Vivani Medical, Inc. Restructuring Costs and Asset Impairment Charges
Vivani Medical, Inc. (VANI) reported Restructuring Costs and Asset Impairment Charges of $1.21 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2022-03-29
- Vivani Medical, Inc. restructuring costs and asset impairment charges for the quarter ending 2020-12-31 was $98.00K.
- Vivani Medical, Inc. restructuring costs and asset impairment charges for the quarter ending 2020-09-30 was $1.00K.
- Vivani Medical, Inc. restructuring costs and asset impairment charges for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Vivani Medical, Inc. restructuring costs and asset impairment charges for the quarter ending 2020-03-31 was $1.11M, a 54.00% decline year-over-year.
- Vivani Medical, Inc. restructuring costs and asset impairment charges for fiscal 2020 was $1.21M, a 53.07% decline from fiscal 2019.
- Vivani Medical, Inc. restructuring costs and asset impairment charges for fiscal 2019 was $2.59M.
| Period end | Restructuring Costs and Asset Impairment Charges 3 month | Restructuring Costs and Asset Impairment Charges 6 month | Restructuring Costs and Asset Impairment Charges 9 month | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2020-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $99.00K derived: sum of 2 quarters · filed 2022-03-29 | $99.00K derived: sum of 3 quarters · filed 2022-03-29 | $1.21M 10-K · filed 2022-03-29 |
| 2020-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.12M 10-Q · filed 2021-11-12 | $1.12M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $1.11M 10-Q · filed 2021-08-13 | $1.11M derived: sum of 3 quarters · filed 2021-08-13 | $1.11M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $1.11M 10-Q · filed 2021-05-13 | $1.11M derived: sum of 2 quarters · filed 2021-05-13 | $1.11M derived: sum of 3 quarters · filed 2021-05-13 | $1.28M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $163.00K derived: sum of 3 quarters · filed 2021-03-16 | $2.59M 10-K · filed 2021-03-16 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $163.00K derived: sum of 2 quarters · filed 2020-11-12 | $2.59M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $2.59M 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $2.42M 10-Q · filed 2020-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |